Outcomes and Therapeutic Management of Bladder Cancer

Outcomes and Therapeutic Management of Bladder Cancer

Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invas...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
Medicine
adjuvant
age
anesthesia recovery periods
biomarkers
bladder cancer
chemotherapy
clear-cell adenocarcinoma
cognitive impairment
female
FOXA1
gamma-cyclodextrins
GATA3
glycogen
human epidermal growth factor receptor 2
immunotherapy
indoleamine 2,3-dioxygenase
intracorporeal neobladder
KRT20
methylation
molecular markers
mRNA
muscle-invasive bladder cancer
n/a
neoadjuvant
neuromuscular blockade
nodal disease
open
outcome
outcomes
PCR
pN1
programmed death ligand-1
propensity score
radical cystectomy
robotic
robotic radical cystectomy
robotic-assisted
SEER program database
sex-sparing
survival
urinary bladder
urothelial carcinoma
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Internet

Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Similar Items